SARS-CoV-2 booster vaccination does not worsen glycemia in people with type 1 diabetes using insulin pumps: an observational study-Reference-Cited by-同舟云学术

SARS-CoV-2 booster vaccination does not worsen glycemia in people with type 1 diabetes using insulin pumps: an observational study

Published:2024-09-10 Issue: Volume: Page:
ISSN:1432-5233
Container-title:Acta Diabetologica
language:en
Short-container-title:Acta Diabetol

Author:

Engelbogen Braden^ORCID,Donaldson Laura^ORCID,McAuley Sybil^ORCID,Fourlanos Spiros^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00592-024-02372-4.pdf

Reference20 articles.

1. Guan W-J, Liang W-H, Zhao Y et al (2020) Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 55:2000547. https://doi.org/10.1183/13993003.00547-2020

2. COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators (2021) Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med 47:60–73. https://doi.org/10.1007/s00134-020-06294-x

3. (2023) WHO roadmap on uses of COVID-19 vaccines in the context of Omicron and high population immunity. In: World Health Organ. https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Vaccines-SAGE-Prioritization-2023.1. Accessed 1 Feb 2024

4. Bianchi FP, Stefanizzi P, Martinelli A et al (2023) COVID-19 vaccination hesitancy in people affected by diabetes and strategies to increase vaccine compliance: a systematic narrative review and meta-analysis. Vaccine 41:1303–1309. https://doi.org/10.1016/j.vaccine.2023.01.036

5. Wang Y, Duan L, Li M et al (2022) COVID-19 vaccine hesitancy and Associated Factors among diabetes patients: a cross-sectional survey in Changzhi, Shanxi, China. Vaccines 10:129. https://doi.org/10.3390/vaccines10010129